You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BBIO Sale Disclosure
Kumar Neil · SEC Form 4 · Filed Sep 21, 2026
Sale
Calculated transaction value
$88.98K
Kumar Neil Chief Executive Officer
BBIO
BridgeBio Pharma
BBIO
Transaction date
Sep 17, 2026
Public filing date
Sep 21, 2026
Filing lag
Filed 4 days later
BBIO daily price context
Close on/before transaction
$67.31
Sep 17, 2026
First close after public filing
$69.23
Sep 22, 2026
30-day return after filing
-2.15%
Through Oct 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,279 shares @ $69.57
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001470831-26-000897
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$690.85K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bridgebio Pharma, Inc. BBIO | Sale | Sep 17, 2026 | $601.87K |
| Bridgebio Pharma, Inc. BBIO Current | Sale | Sep 17, 2026 | $88.98K |